• Something wrong with this record ?

The barrier function of organotypic non-melanoma skin cancer models

C. Zoschke, M. Ulrich, M. Sochorová, C. Wolff, K. Vávrová, N. Ma, C. Ulrich, JM. Brandner, M. Schäfer-Korting,

. 2016 ; 233 (-) : 10-8. [pub] 20160427

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

Non-melanoma skin cancer (NMSC) is the most frequent human cancer with continuously rising incidences worldwide. Herein, we investigated the molecular basis for the impaired skin barrier function of organotypic NMSC models. We unraveled disturbed epidermal differentiation by reflectance confocal microscopy and histopathological evaluation. While the presence of claudin-4 and occludin were distinctly reduced, zonula occludens protein-1 was more wide-spread, and claudin-1 was heterogeneously distributed within the NMSC models compared with normal reconstructed human skin. Moreover, the cancer altered stratum corneum lipid packing and profile with decreased cholesterol content, increased phospholipid amount, and altered ceramide subclasses. These alterations contributed to increased surface pH and to 1.5 to 2.6-fold enhanced caffeine permeability of the NMSC models. Three topical applications of ingenol mebutate gel (0.015%) caused abundant epidermal cell necrosis, decreased Ki-67 indices, and increased lactate dehydrogenase activity. Taken together, our study provides new biological insights into the microenvironment of organotypic NMSC models, improves the understanding of the disease model by revealing causes for impaired skin barrier function in NMSC models at the molecular level, and fosters human cell-based approaches in preclinical drug evaluation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017282
003      
CZ-PrNML
005      
20180515103126.0
007      
ta
008      
180515s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jconrel.2016.04.037 $2 doi
035    __
$a (PubMed)27130695
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Zoschke, Christian $u Institute for Pharmacy, Freie Universität Berlin, Königin-Luise-Str. 2+4, 14195 Berlin, Germany.
245    14
$a The barrier function of organotypic non-melanoma skin cancer models / $c C. Zoschke, M. Ulrich, M. Sochorová, C. Wolff, K. Vávrová, N. Ma, C. Ulrich, JM. Brandner, M. Schäfer-Korting,
520    9_
$a Non-melanoma skin cancer (NMSC) is the most frequent human cancer with continuously rising incidences worldwide. Herein, we investigated the molecular basis for the impaired skin barrier function of organotypic NMSC models. We unraveled disturbed epidermal differentiation by reflectance confocal microscopy and histopathological evaluation. While the presence of claudin-4 and occludin were distinctly reduced, zonula occludens protein-1 was more wide-spread, and claudin-1 was heterogeneously distributed within the NMSC models compared with normal reconstructed human skin. Moreover, the cancer altered stratum corneum lipid packing and profile with decreased cholesterol content, increased phospholipid amount, and altered ceramide subclasses. These alterations contributed to increased surface pH and to 1.5 to 2.6-fold enhanced caffeine permeability of the NMSC models. Three topical applications of ingenol mebutate gel (0.015%) caused abundant epidermal cell necrosis, decreased Ki-67 indices, and increased lactate dehydrogenase activity. Taken together, our study provides new biological insights into the microenvironment of organotypic NMSC models, improves the understanding of the disease model by revealing causes for impaired skin barrier function in NMSC models at the molecular level, and fosters human cell-based approaches in preclinical drug evaluation.
650    _2
$a kofein $x farmakologie $7 D002110
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a kokultivační techniky $7 D018920
650    _2
$a diterpeny $x farmakologie $7 D004224
650    _2
$a esterasy $x metabolismus $7 D004950
650    _2
$a fibroblasty $x metabolismus $7 D005347
650    _2
$a lidé $7 D006801
650    _2
$a keratinocyty $x metabolismus $7 D015603
650    _2
$a metabolismus lipidů $7 D050356
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a kůže $x účinky léků $x metabolismus $7 D012867
650    _2
$a nádory kůže $x metabolismus $7 D012878
650    _2
$a proteiny těsného spoje $x metabolismus $7 D062725
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ulrich, Martina $u Collegium Medicum Berlin, Luisenstr. 54, 10117 Berlin, Germany; Department of Dermatology, Venereology and Allergology, Skin Cancer Center Charité, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
700    1_
$a Sochorová, Michaela $u Faculty of Pharmacy, Charles University in Prague, Akademika Heyrovského 1203, 50005 Hradec Králové, Czech Republic.
700    1_
$a Wolff, Christopher $u Institute for Pharmacy, Freie Universität Berlin, Königin-Luise-Str. 2+4, 14195 Berlin, Germany.
700    1_
$a Vávrová, Kateřina $u Faculty of Pharmacy, Charles University in Prague, Akademika Heyrovského 1203, 50005 Hradec Králové, Czech Republic.
700    1_
$a Ma, Nan $u Institute of Biomaterial Science, Department of Biocompatibility, Helmholtz Centre for Materials and Coastal Research, Kantstr. 55, 14153 Teltow, Germany.
700    1_
$a Ulrich, Claas $u Department of Dermatology, Venereology and Allergology, Skin Cancer Center Charité, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
700    1_
$a Brandner, Johanna M $u Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.
700    1_
$a Schäfer-Korting, Monika $u Institute for Pharmacy, Freie Universität Berlin, Königin-Luise-Str. 2+4, 14195 Berlin, Germany. Electronic address: monika.schaefer-korting@fu-berlin.de.
773    0_
$w MED00002621 $t Journal of controlled release official journal of the Controlled Release Society $x 1873-4995 $g Roč. 233, č. - (2016), s. 10-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27130695 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180515103259 $b ABA008
999    __
$a ok $b bmc $g 1300906 $s 1014122
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 233 $c - $d 10-8 $e 20160427 $i 1873-4995 $m Journal of controlled release $n J Controlled Release $x MED00002621
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...